$ZBRA

Zebra Technologies Corporation (ZBRA) Q3 Sales Rose to $1.614B

Zebra Technologies (ZBRA) reported Q3 net sales of $1.614B, up from $1.320B a year earlier, and non-GAAP diluted EPS of $4.95, up from $3.88. The company expects Q4 sales growth of 10%-14% and full-year free cash flow of at least $1B.

Original reporting
Published Nov 3, 2026, 11:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 11:39 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Zebra Technologies Corporation (ZBRA) Q3 Sales Rose to $1.614B — source image
Decision brief

The 30-second read

$ZBRABullishMed
01

Why it matters

The key tradable elements are the Q3 print and the explicit Q4 sales growth range, plus the full-year free cash flow floor, which together shape near-term earnings revisions and cash-flow expectations.

02

Market read

Company-specific earnings and guidance details are likely to drive revisions and near-term positioning.

03

What to watch

The article does not provide segment margins, backlog, or consensus comparisons, so traders may need to verify whether the guidance implies acceleration or merely normalization.

Relevance 9/10Novelty 8/10Timing: reported Q3 results with Q4 and full-year outlook

Background

The piece summarizes Zebra’s Q3 performance and pairs it with an increased full-year outlook, citing year-over-year sales and EPS growth.

Company-level read

Ticker impact

$ZBRABullishMedium confidence
Context

Zebra reported Q3 net sales of $1.614B and non-GAAP EPS of $4.95, plus Q4 sales growth guidance of 10% to 14% YoY.

Expected impact

Likely upward pressure as traders price in stronger Q4 growth and at least $1B full-year free cash flow.

Evidence & confidence

The article contains the company’s own quarterly results and explicit Q4 and full-year targets, which are direct inputs to earnings and cash-flow expectations.

Market effects

Signals demand and margin/cash-flow trajectory for industrial automation and enterprise hardware supply chains tied to Zebra’s printing and scanning ecosystem.

No specific regional macro linkage stated; impact is primarily company-specific.

Limited broader market relevance beyond potential read-through to enterprise automation capex sentiment.

Counterpoint

If the market had already anticipated strong Q4 growth, the stock reaction could be muted or turn negative on any perceived conservatism in the free-cash-flow floor versus expectations.

Key entities

  • Zebra Technologies Corporation

    Reported Q3 net sales and non-GAAP EPS, and provided Q4 sales growth guidance and a full-year free cash flow target.

Related articles

$ZBRAHighAI 9/10

Zebra Q3 2026 slides: record sales hit by margin squeeze

Zebra Technologies reported Q3 2026 sales of $1.61B, up 22.3% YoY, with EPS of $4.95. Despite record sales, margins shrank due to memory component cost inflation. The stock fell 7.65% post-earnings. The company raised full-year guidance but faces $145M in cost headwinds. Free cash flow reached $661M YTD, and $643M was spent on share repurchases. Growth was broad-based across segments and regions, with strong demand for AI and automation solutions.

$ZBRAHighAI 8/10

Zebra Technologies Announces Third Quarter 2026 Results

ZEBRA TECHNOLOGIES CORP (ZBRA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Zebra Technologies Corporation 3 Overlook Point Lincolnshire, IL 60069 USA +1 847 634 6700 www.zebra.com Zebra Technologies Announces Third Quarter 2026 Results Strong growth across segments and regions reflects customer investment in automation and productivity Rais

$ZBRAHighAI 9/10

Why is Zebra Technologies stock tumbling today?

Zebra Technologies (ZBRA) shares fell 13.1% in pre-market trading after Q3 2026 earnings beat estimates but Q4 guidance missed expectations. Adjusted EPS was $4.95 vs. $4.89 estimate, revenue was $1.61B vs. $1.57B estimate. Gross margin declined to 45.7% from 48.0% due to higher costs. Wall Street Zen upgraded ZBRA to 'Strong-Buy'.